Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention

NCT05773950 · clinicaltrials.gov ↗
NA
Phase
ENROLLING_BY_INVITATION
Status
144
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center